Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center.


Journal

Journal of oncology practice
ISSN: 1935-469X
Titre abrégé: J Oncol Pract
Pays: United States
ID NLM: 101261852

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 16 10 2019
medline: 18 8 2020
entrez: 16 10 2019
Statut: ppublish

Résumé

Advance care planning (ACP) supports national priorities of patient engagement, person-centered care, and safety. A systematic approach is uncommon in most care settings. Our institution offers all patients with cancer new to the institution an opportunity to select and prepare a medical decision maker (MDM) after social work counseling. The goals of this study were to determine the success of a systematic institutional process for selecting a prepared MDM. The primary objectives were that (1) 70% or more of new patients would have one or more documented social work ACP discussions by the third office visit within 4 months, and (2) there would be a two-fold increase in scanned medical power of attorney (MPOA) documents available in the electronic health record (EHR). The secondary objectives were (1) improved surrogate preparedness for medical decision making, and (2) to determine whether patients with metastatic disease demonstrated greater readiness for selection of an MDM than those with localized disease. We conducted a retrospective chart review of consecutive gynecology oncology outpatients. Of 133 patients, 93 (70%) had metastatic disease. The median number of visits was two (one to three). Forty-seven patients (39.3%) met with social work by visit 3. Review of ACP notes suggested that most patients were in the early stages of selecting a prepared MDM. At visit 1, 39 (29.3%) reported having an advance directive document; 14 (10.5%) had an MPOA in the EHR. There was no increase by visit 3. Fewer patients with metastatic disease than those with localized cancer (32.3% Current processes fail to engage patients in selecting and preparing an MDM.

Identifiants

pubmed: 31613720
doi: 10.1200/JOP.19.00109
pmc: PMC7846063
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1092-e1097

Subventions

Organisme : NCI NIH HHS
ID : K07 CA201013
Pays : United States

Références

J Palliat Med. 2018 Dec;21(12):1778-1782
pubmed: 30129808
Palliat Support Care. 2015 Jun;13(3):795-800
pubmed: 24914566
Ann Intern Med. 2010 Aug 17;153(4):256-61
pubmed: 20713793
J Pain Symptom Manage. 2013 Sep;46(3):355-65
pubmed: 23200188
J Am Geriatr Soc. 2018 Oct;66(10):2017-2021
pubmed: 30289968
JAMA Intern Med. 2019 Jun 1;179(6):751-759
pubmed: 30870563
J Am Geriatr Soc. 2010 Jul;58(7):1249-55
pubmed: 20649688
JAMA Oncol. 2019 Jun 1;5(6):801-809
pubmed: 30870556
J Clin Oncol. 2012 Dec 10;30(35):4387-95
pubmed: 23150700
Congenit Heart Dis. 2018 May;13(3):362-368
pubmed: 29457357
J Pain Symptom Manage. 2017 Sep;54(3):383-386
pubmed: 28797865
J Am Geriatr Soc. 2010 Dec;58(12):2329-36
pubmed: 21143441
Lancet Oncol. 2017 Sep;18(9):e543-e551
pubmed: 28884703
J Pain Symptom Manage. 2019 Jan;57(1):112-117.e2
pubmed: 30595147
JAMA Pediatr. 2013 May;167(5):460-7
pubmed: 23479062
J Palliat Med. 2011 Nov;14(11):1224-30
pubmed: 21870958
Dtsch Arztebl Int. 2014 Jan 24;111(4):50-7
pubmed: 24612497
BMC Palliat Care. 2018 May 24;17(1):78
pubmed: 29793469
J Am Geriatr Soc. 2019 Jun;67(6):1278-1285
pubmed: 30854643
Palliat Med. 2016 Sep;30(8):720-9
pubmed: 26908645
J Palliat Med. 2010 Jul;13(7):837-40
pubmed: 20636154
BMJ. 2010 Mar 23;340:c1345
pubmed: 20332506
J Hosp Palliat Nurs. 2019 Feb;21(1):71-79
pubmed: 30608360
Pediatrics. 2016 Dec;138(6):
pubmed: 27940700
JAMA. 2008 Oct 8;300(14):1665-73
pubmed: 18840840
JAMA Intern Med. 2014 Dec;174(12):1994-2003
pubmed: 25330167

Auteurs

Donna S Zhukovsky (DS)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Pamela T Soliman (PT)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Boby Mathew (B)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Sarah Mills (S)

Seton Medical Center and University of Texas, Austin, TX.

Diane Bodurka (D)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Michael Frumovitz (M)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Larissa A Meyer (LA)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Shannon Westin (S)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Marisa Nowitz (M)

Baylor College of Medicine and Texas Children's Hospital, Houston, TX.

LaShan Archie (L)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Shauna Fenton (S)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Kai Lang (K)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Janet L Williams (JL)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Valentine Boving (V)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Eduardo Bruera (E)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH